11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa

      Read this article at

      ScienceOpenPublisher
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Candida auris is a multidrug-resistant fungal pathogen that is endemic in South African hospitals. We tested bloodstream C. auris isolates that were submitted to a reference laboratory for national laboratory-based surveillance for candidemia in 2016 and 2017.

          ABSTRACT

          Candida auris is a multidrug-resistant fungal pathogen that is endemic in South African hospitals. We tested bloodstream C. auris isolates that were submitted to a reference laboratory for national laboratory-based surveillance for candidemia in 2016 and 2017. We confirmed the species identification by phenotypic/molecular methods. We tested susceptibility to amphotericin B, anidulafungin, caspofungin, micafungin, itraconazole, posaconazole, voriconazole, fluconazole, and flucytosine using broth microdilution and Etest methods. We interpreted MICs using tentative breakpoints. We sequenced the genomes of a subset of isolates and compared them to the C. auris B8441 reference strain. Of 400 C. auris isolates, 361 (90%) were resistant to at least one antifungal agent, 339 (94%) to fluconazole alone (MICs of ≥32 µg/ml), 19 (6%) to fluconazole and amphotericin B (MICs of ≥2 µg/ml), and 1 (0.3%) to amphotericin B alone. Two (0.5%) isolates from a single patient were pan-resistant (resistant to fluconazole, amphotericin B, and echinocandins). Of 92 isolates selected for whole-genome sequencing, 77 clustered in clade III, including the pan-resistant isolates, 13 in clade I, and 2 in clade IV. Eighty-four of the isolates (91%) were resistant to at least one antifungal agent; both resistant and susceptible isolates had mutations. The common substitutions identified across the different clades were VF125AL, Y132F, K177R, N335S, and E343D in ERG11 ; N647T in MRR1 ; A651P, A657V, and S195G in TAC1b ; S639P in FKS1HP1 ; and S58T in ERG3 . Most South African C. auris isolates were resistant to azoles, although resistance to polyenes and echinocandins was less common. We observed mutations in resistance genes even in phenotypically susceptible isolates.

          Related collections

          Author and article information

          Contributors
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          Journal
          Antimicrobial Agents and Chemotherapy
          Antimicrob Agents Chemother
          American Society for Microbiology
          0066-4804
          1098-6596
          August 17 2021
          August 17 2021
          : 65
          : 9
          Affiliations
          [1 ]National Institute for Communicable Diseases, Centre for Healthcare-Associated Infections, Antimicrobial Resistance, and Mycoses, National Health Laboratory Service, Johannesburg, South Africa
          [2 ]School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
          [3 ]National Institute for Communicable Diseases, Sequencing Core Facility, National Health Laboratory Service, Johannesburg, South Africa
          [4 ]Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
          [5 ]National Health Laboratory Service, Chris Hani Baragwaneth Academic Hospital, Soweto, South Africa
          [6 ]National Health Laboratory Service, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa
          [7 ]AMPATH National Laboratory Service, Centurion, South Africa
          [8 ]Lancet Laboratories, Durban, South Africa
          [9 ]Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
          Article
          10.1128/AAC.00517-21
          6b66f477-fef4-4f26-910e-7e3e18f1bcd4
          © 2021

          https://doi.org/10.1128/ASMCopyrightv2

          https://journals.asm.org/non-commercial-tdm-license

          History

          Comments

          Comment on this article